Pingna Deng
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- Cancer Genomics and Diagnostics
Papers in
- Co-authors
- Ronald Anthony DePinho (4 shared papers)Yanru Wang (3 shared papers)Xiaoying Shang (3 shared papers)James W. Horner (2 shared papers)Xin Lü (2 shared papers)Dean Y. Maeda (1 shared paper)Qing Chang (1 shared paper)Shan Jiang (1 shared paper)
- Journals
- Nature (4 papers)Cancer Discovery (4 papers)Nature Communications (2 papers)Cancer Research (2 papers)Journal for ImmunoTherapy of Cancer (1 paper)
- Partner nations
- United StatesChinaDenmark
In The Last Decade
Pingna Deng
17 papers receiving 2.4k citations
Pingna Deng's Hit Papers
Peers
Comparison fields: 5 of 75
- Oncology 807
- Cancer Research 325
- Genetics 189
- Immunology 317
- Cell Biology 222
Countries citing papers authored by Pingna Deng
This map shows the geographic impact of Pingna Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pingna Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pingna Deng more than expected).
Fields of papers citing papers by Pingna Deng
This network shows the impact of papers produced by Pingna Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pingna Deng. The network helps show where Pingna Deng may publish in the future.
Co-authors
The 25 scholars most cited alongside Pingna Deng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 465 | |
| 2 | Effective combinatorial immunotherapy for castration-resistant prostate cancer Hit paper breakdown → | 2017 | 465 |
| 3 | 2012 | 283 | |
| 4 | 2016 | 229 | |
| 5 | 2017 | 178 | |
| 6 | 2020 | 172 | |
| 7 | 2019 | 165 | |
| 8 | 2020 | 91 | |
| 9 | 2022 | 73 | |
| 10 | 2020 | 59 | |
| 11 | 2020 | 57 | |
| 12 | 2021 | 49 | |
| 13 | 2021 | 43 | |
| 14 | 2024 | 21 | |
| 15 | 2015 | 19 | |
| 16 | 2018 | 15 | |
| 17 | 2022 | 5 |
About Pingna Deng
Pingna Deng is a scholar working on Oncology, Genetics, Pulmonary and Respiratory Medicine, Immunology and Physiology, having authored 17 papers that have together received 2.4k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (3 papers), Pancreatic and Hepatic Oncology Research (3 papers), Prostate Cancer Treatment and Research (3 papers), Immune cells in cancer (2 papers), Glioma Diagnosis and Treatment (2 papers), Cancer, Hypoxia, and Metabolism (1 paper), Telomeres, Telomerase, and Senescence (1 paper) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Oncology (807 citations), Cancer Research (325 citations), Genetics (189 citations), Immunology (317 citations) and Cell Biology (222 citations). Pingna Deng has collaborated with scholars based in United States, China and Denmark. Frequent co-authors include Ronald Anthony DePinho, Yanru Wang, Xiaoying Shang, James W. Horner, Xin Lü, Dean Y. Maeda, Qing Chang, Shan Jiang, Erin Paul and John A. Zebala. Their work appears in journals such as Nature, Cancer Discovery, Nature Communications, Cancer Research and Journal for ImmunoTherapy of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.